Cue Biopharma Inc (CUE)
1.025
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
1.01
-0.02
(-1.46%)
After-Hours: 05:14
Cue Biopharma Total Liabilities (Quarterly): 19.44M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 33.55M |
| GlycoMimetics Inc | 4.322M |
| FibroGen Inc | 466.12M |
| Cidara Therapeutics Inc | 46.70M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.81M |
| Shareholders Equity (Quarterly) | 25.37M |
| Debt to Equity Ratio | 0.2086 |
| Current Ratio | 2.219 |
| Net Debt Paydown Yield | 2.10% |